STRIVE INC CLASS A (ASST)
Health Care · Diversified Financials / Medical Technology · NASDAQ
A holding company operating at the intersection of investment advisory services, medical technology, and digital asset ownership.
What STRIVE INC CLASS A does
Strive, Inc. operates as a diversified holding company with interests spanning investment advisory services and the medical device industry. Through its business units, the company manages investment funds and develops or commercializes medical technologies. The company maintains a significant portfolio of digital assets.
Themes: investment management, medical devices, cryptocurrency assets
Fundamentals
- Price$28.23 as of 2026-10-08 close
- Market cap$1.1B date unknown (no dated share count)
- 1-year return-29.1% 2025-10-08 close $39.80 → 2026-10-08 close $28.23
- P/En/a negative earnings
- Net margin-3406.5% FY2024, SEC XBRL
- ROE-92.5% FY2024, SEC XBRL
- Debt / equity0.01 as of 2026-09-03
- Revenue growth (YoY)+128.7% FY2024 vs FY2023, SEC XBRL
- Revenue CAGR (3y)-8.6% SEC XBRL
- Beta1.51 as of 2026-09-03
- Last reported earnings2026-08-10 SEC EDGAR Form 8-K (Item 2.02)
Dividend: pays a dividend.
How ASST compares in its sector
- net profit marginbottom 10% 430 covered Health Care peers, as of 2026-09-03
- operating marginbottom 10% 417 covered Health Care peers, as of 2026-09-03
- return on equitybottom 25% 510 covered Health Care peers, as of 2026-09-03
- 3-year revenue CAGRbottom 25% 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)middle range 494 covered Health Care peers, as of FY2024
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How STRIVE INC CLASS A looks technically
STRIVE INC CLASS A (ASST) is trading 78.7% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 23 trading days ago — a "golden cross", a bullish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 54, with buyers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 56, neither overbought (above 70) nor oversold (below 30). It made a new 20-day high about 14 trading days ago. It is 48.5% below its highest point of the past year. Day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 1% of the past ~6 months), which often precedes a bigger move.
Trend
9
| Distance from the 200-day | it is trading 78.7% above its 200-day average, the long-term trend line — a longer-term uptrend | +78.7% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $22.38 | $22.38 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $15.80 | $15.80 |
| Swing structure | each recent peak has been higher than the one before it and each dip has been shallower — the pattern chart-watchers call an uptrend, which describes where price has already been and not where it goes next | higher highs and higher lows |
| Last swing turn | its last significant turn was a swing high 17 calendar days ago — the swings before that are what the structure reading is measured on | 17 sessions |
| Wave structure | its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in the fourth leg, a pullback against that upward direction; the labelling fails if price closes below 12.97. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a completed three-part correction. | possible upward five-wave sequence, in wave 4 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 23 trading days ago — a "golden cross", a bullish long-term signal | 23 sessions |
| Above the 200-day after a dip | it recently dipped to its 200-day average (the long-term trend line) and has since climbed back above it — now about 78.7% above | +78.7% |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 54, with buyers in control | 54.1 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 56, neither overbought (above 70) nor oversold (below 30) | 56.0 |
|---|---|---|
| Position in its 14-day range | it is trading near the bottom of its 14-day range ($27.33 to $32.08) — its "stochastic" reading is 19 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 19.0 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in negative territory (momentum leaning bearish) | 13 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $54.80 | $54.80 |
|---|---|---|
| From the 52-week high | it is 48.5% below its 52-week high (its highest price of the past year) | -48.5% |
| Above the 52-week low | it is 302.1% above its 52-week low (its lowest price of the past year) | +302.1% |
| Below the 52-week high | it is 48.5% below its highest point of the past year | 48.5% |
| Since a 20-day breakout | it made a new 20-day high about 14 trading days ago | 14 sessions |
| Since a 55-day breakout | it made a new 55-day high about 14 trading days ago | 14 sessions |
| All-time high | its highest closing price on record is $698.00 (set on 2023-02-03) | $698.00 |
| Given back of the 52-week move | over the past year its closes ranged ($7.17 to $52.00), and it has recovered around half of its fall from last year’s high — 47% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $34.87 to $36.31. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 47.0% |
| From the all-time high | it is 96.0% below its all-time high | -96.0% |
| Nearest price level | it is trading 21.1% below a resistance level at $34.20 — a price it turned at twice since 2025-01-22, most recently on 2025-11-10. Since 2024-10-08 it has 8 such levels below the current price and 1 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +21.1% |
| All-time low | its lowest closing price on record is $6.70 (set on 2024-12-20) | $6.70 |
| Above the all-time low | it is 321.3% above its all-time low | +321.3% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 1% of the past ~6 months), which often precedes a bigger move | 0th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $1.75 between its high and its low — about 6.2% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $1.75 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $27.28 and $30.95 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $27.28 – $29.12 – $30.95 |
| Typical daily range (% of price) | its price moves about 6.2% in a typical session — more volatile than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 6.2% |
| Stretch from the 200-day average | it is trading 7.1 daily ranges above its 200-day average price (78.7% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 7.1 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.82× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Price gaps
3
| Gap at the open | it opened on 2026-10-08 1.7% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -1.7% |
|---|---|---|
| Open gap | it gapped 3.4% below the previous close 1 session ago and has not traded back through the level it left behind at 29.75 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | -3.4% |
| Gap filled | a 3.9% gap up opened on 2026-10-02 has been "filled" 4 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 4 sessions ago |
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 2.9 percentage points (the stock gained 3.9% while the market gained 1.0%) | +2.9% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 124.0 percentage points (the stock gained 127.8% while the market gained 3.8%) | +124.0% |
| vs market, 6 months | over the past 6 months this stock beat the market by 161.5 percentage points (the stock gained 179.0% while the market gained 17.5%) | +161.5% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 44.0 percentage points (the stock lost 29.1% while the market gained 15.0%) | -44.0% |
Signal agreement
2
| Bullish technical signals | 6 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, a strong uptrend, with buyers in control, outperforming the market over 6 months, near the bottom of its 14-day range (oversold), trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 6 of 9 |
|---|---|---|
| Bearish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bearish state: MACD momentum is negative — these describe past price behaviour, not a forecast | 1 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 50% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is moderate, spanning 4.5% of the share price. | +49.6% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 56% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $18.13 — a volume-weighted average of daily closes over 190 sessions, not a true tick-by-tick VWAP. | +55.8% |
|---|---|---|
| Vs the average paid since it last reported | the price is 12% above the average price paid since it last reported on 2026-08-10 (its 10-Q), so the typical buyer over that stretch is showing a gain. That average is $25.15 — a volume-weighted average of daily closes over 43 sessions, not a true tick-by-tick VWAP. | +12.2% |
Price levels it has turned at before
ASST last closed at $28.23 on 2026-10-08. Since 2024-10-08 it has turned at 8 prices below its last close and 1 above; the 3 nearest below and the nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $34.20 | Resistance | 21.1% above the last close | turned there twice · 2025-01-22 to 2025-11-10 |
| $18.81 | Support | 33.4% below the last close | turned there twice · 2025-11-21 to 2025-12-22 |
| $17.95 | Support | 36.4% below the last close | turned there twice · 2024-10-22 to 2026-04-22 |
| $15.61 | Support | 44.7% below the last close | turned there twice · 2025-10-22 to 2025-12-15 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 4 of five, a pullback against that direction.
This labelling fails — stops being a possible reading at all — if it closes below $12.97.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $21.91 and $27.21 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a completed three-part correction, which fails on a close above $31.95.
This reading has stood for 9 trading days, since 2026-09-28.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Recent golden cross (50-day crossed above 200-day) · Tested and reclaimed 200-day support · Pulled back from the 12-month high · in a Bollinger Band volatility squeeze · in a strong, established uptrend (ADX) | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low · bollinger bands
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingStrong Buy (1.20 mean, 1=Strong Buy…5=Strong Sell) — 5 analysts
- Mean price target$33.20 range $21.00 – $44.00; median $33.00
Analyst estimates, as of 2026-10-05. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for ASST
- Consensus EPS estimate-$0.225 next reporting period, as of 2026-10-05
- Estimate change, 30 days+$0.02 from -$0.245, on 2026-09-01, 34-day window
- Readings revised upward14% of 7 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["High volatility in the value of digital assets significantly impacts financial performance.","Substantial net losses and accumulated deficit raise concerns regarding future capital requirements.","Exposure to risks related to medical device market competition and regulatory environments."]
What changed in the latest 10-Q
AI-assisted comparison of ASST's 10-Q filed 2026-08-10 against the prior one filed 2026-05-14.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing adds a 'Bitcoin Update' subsection under Recent Developments stating that during the three months ended June 30, 2026, the Company acquired 6,236 bitcoin at an average cost of $74,290 per bitcoin, and as of June 30, 2026, the Company holds 19,864 bitcoin.
- Newer filing adds a subsection under Recent Developments titled 'Retirement of 4.25% Convertible Senior Notes due 2030' stating that during the three months ended June 30, 2026, the Company retired the remaining long-term notes payable, at fair value, resulting in no Semler Convertible Notes outstanding as of June 30, 2026.
- Newer filing adds a 'Results of Operations' section with a comparison table for the three months ended June 30, 2026 (Successor) versus June 30, 2025 (Predecessor), including investment advisory fees, medical device revenues, and other revenue figures.
- Newer filing states that SATA Stock is the first listed security in US capital markets history to pay dividends to holders each business day.
- Removed:
- Older filing's subsection 'Business combination with Semler Scientific, Inc.' describing the September 22, 2025 merger agreement, the January 16, 2026 merger completion, and acquisition of 5,048 bitcoin, is not present in the newer filing.
- Older filing's 'Capital Markets Activity' subsection includes details of a January 27, 2026 public follow-on offering of 1,320,000 shares of SATA Stock with approximately $109.3 million net proceeds; this follow-on offering disclosure is not present in the newer filing's Recent Developments.
- Older filing's 'Partial Retirement of 4.25% Convertible Senior Notes due 2030' subsection with details of the supplemental indenture and conversion rights is not present in the newer filing.
- Reworded:
- Newer filing changes the Overview description from 'a structured finance company and institutional asset manager' to 'a structured finance company'.
- Newer filing changes 'a publicly traded security' to 'this publicly traded security' when describing SATA Stock.
- Newer filing changes 'Beyond balance sheet strategy' to 'Beyond our balance sheet strategy'.
- Newer filing changes 'developed our SATA Stock, our perpetual preferred equity instrument, that incorporates' to 'developed SATA Stock, our perpetual preferred equity instrument that incorporates'.
- Newer filing changes 'Through these innovations, Strive seeks' to 'Through Strive's continued innovation, we seek'.
- Newer filing changes the bitcoin strategy description from referencing 'beta' initiatives and 'alpha' strategies to describing 'primary focus' activities including open market purchases and other strategies with a 'differentiated value proposition relative to open market purchases'.
- Newer filing changes AUM as of date from 'As of March 31, 2026, the Company manages over $2.5 billion in AUM' to 'As of June 30, 2026, the Company manages over $2.8 billion in AUM'.
- Newer filing changes digital assets figures: from $929.4 million and 13,628 bitcoin as of March 31, 2026 to $1.2 billion and 19,864 bitcoin as of June 30, 2026.
- Newer filing changes cash and cash equivalents from $95.1 million as of March 31, 2026 and $87.6 million as of May 12, 2026 to $145.5 million as of June 30, 2026 and $154.9 million as of August 7, 2026.
- Newer filing changes STRC Stock fair value from $50.5 million as of March 31, 2026, and $50.5 million as of May 12, 2026, to $42.9 million as of June 30, 2026 and $48.0 million as of August 7, 2026.
- Newer filing changes bitcoin treasury total from 15,009 bitcoin as of May 12, 2026 to 20,167 bitcoin as of August 7, 2026.
- Newer filing changes the Recent Developments heading 'Change to Daily Dividend Payments' to 'Daily Dividend Payments on Variable Rate Series A Perpetual Preferred Stock' and changes wording to note the certificate was filed with the Nevada Secretary of State on May 13, 2026.
- Newer filing revises capital markets activity disclosure to report issuance of 12.8 million shares of Class A common stock for $211.3 million and 3,456,308 shares of SATA Stock for $345.7 million during the three months ended June 30, 2026, under ATM programs, instead of the older filing's follow-on offering details.
- Newer filing adds the statement 'these activities provide recurring, fee-based revenue streams which increase with AUM' in the Overview section regarding AUM.
- Notes:
- The newer filing's Results of Operations table is truncated in the provided text after 'Other revenue' figures, so a complete comparison of the Results of Operations section cannot be fully assessed.
- The older filing text appears to be truncated mid-sentence in the 'Partial Retirement of 4.25% Convertible Senior Notes due 2030' subsection, limiting full comparison of that content.
Risk Factors
- Added:
- Newer filing (2026-08-10) states: 'There were no material changes to our risk factors during the three months ended June 30, 2026.'
- Newer filing (2026-08-10) adds 'Unregistered Sales of Equity Securities' text stating there were no unregistered sales of the Company's equity securities during the three months ended June 30, 2026.
- Newer filing (2026-08-10) adds a new section 'Adoption of Short-Term Incentive Plan' describing the Strive, Inc. Short-Term Incentive Plan adopted on August 7, 2026.
- Newer filing (2026-08-10) adds a new section 'Grant of Performance Stock Units' describing PSU grants approved on August 7, 2026 to named executive officers and certain other senior employees.
- Removed:
- Older filing (2026-05-14) contains 'Unregistered Sales of Equity Securities' text describing the January 22, 2026 exchange agreements with certain holders of the 4.25% Convertible Senior Notes due 2030 for approximately 929,999 newly issued shares of SATA Stock; this text is removed in the newer filing.
- Older filing (2026-05-14) contains exhibit entries 4.1, 4.2, 4.3 (indenture and supplemental indenture related to the 4.25% Convertible Senior Notes due 2030), 101.DEF, 101.LAB, 101.PRE, and 104 in the Index to Exhibits; these are not present in the newer filing's exhibit list.
- Reworded:
- Older filing (2026-05-14) states: 'There were no material changes to our risk factors during the three months ended March 31, 2026.' Newer filing (2026-08-10) states: 'There were no material changes to our risk factors during the three months ended June 30, 2026.' (change in covered quarter end date)
- Older filing (2026-05-14) 'Purchases of Equity Securities' states no repurchases occurred 'during the three months ended March 31, 2026.' Newer filing (2026-08-10) states no repurchases occurred 'during the three months ended June 30, 2026.' (change in covered quarter end date)
- Older filing (2026-05-14) exhibit 3.1 is 'Certificate of Change of Strive, Inc., as filed with the Nevada Secretary of State on February 3, 2026 and effective on February 6, 2026.' Newer filing (2026-08-10) exhibit 3.1 is 'Amended and Restated Certificate of Designation relating to the Variable Rate Series A Perpetual Preferred Stock, as filed with the Nevada Secretary of State on May 13, 2026 (effective June 15, 2026).' (exhibit 3.1 content changed)
- Newer filing (2026-08-10) adds exhibit entries 3.2, 3.3, 10.1, 10.2, 10.3, 10.4; older filing (2026-05-14) includes exhibit 3.2 as 'Amended and Restated Certificate of Designation relating to the Variable Rate Series A Perpetual Preferred Stock' marked as filed/furnished herewith (different from newer filing's 3.2).
- Notes:
- The provided texts are excerpts of the full sections, not complete filings. The comparison covers only the included portions of Items 1A through 6.
- Exhibit entries and text from Item 5 of the newer filing include other sections beyond 'Risk Factors'; only those portions visible in the supplied texts were compared.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
1 open-market purchase and 6 open-market sales by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
- Last 30 days · read to 2026-10-040 buys · 6 sells ($3M) — 6 selling insiders
- Last 90 days · read to 2026-10-041 buy ($199386) · 6 sells ($3M) — 1 buying, 6 selling insiders
- Last 180 days · read to 2026-10-041 buy ($199386) · 6 sells ($3M) — 1 buying, 6 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-10-05. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about ASST's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
4 institutional 13F filers reported holding ASST as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 4
- Reported shares held 25,674,558
- Reported value $280,109,429
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 4 increased, 0 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about ASST's institutional holders → See what each manager we track holds →
Short interest (FINRA)
ASST had 23,944,194 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
Short interest as a percent of shares outstanding is not shown for ASST because we do not hold a verified share count to divide it by. The reported figures above are unaffected.
- Reported short interest (shares) 23,944,194
- Prior settlement (shares) 19,763,263
- Reported change 21.16%
- Days to cover (reported) 2.38
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- BlackRock (BLK)
- State Street (STT)
- Vanguard Group
- Semler Scientific (SMLR)
- Medtronic (MDT)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare ASST vs…
STRIVE INC CLASS A is found in…
Frequently asked questions
What does STRIVE INC CLASS A (ASST) do?
Strive, Inc. operates as a diversified holding company with interests spanning investment advisory services and the medical device industry. Through its business units, the company manages investment funds and develops or commercializes medical technologies. The company maintains a significant portfolio of digital assets.
What sector is STRIVE INC CLASS A (ASST) in?
STRIVE INC CLASS A (ASST) is classified in the Health Care sector. Its industry is Diversified Financials / Medical Technology. It trades on NASDAQ.
Does ASST pay a dividend?
Yes — STRIVE INC CLASS A (ASST) pays a dividend (market data, as of 2026-09-03). Informational only — not financial advice.
Who are STRIVE INC CLASS A's (ASST) competitors?
Notable peers of STRIVE INC CLASS A (ASST) include BlackRock, State Street, Vanguard Group, Semler Scientific and Medtronic. This peer set is informational only — not financial advice.
Is STRIVE INC CLASS A (ASST) overbought or oversold right now?
STRIVE INC CLASS A (ASST) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 56, in the neutral middle (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on ASST come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.